Achaogen, Inc. Company Profile

14:46 EDT 27th October 2016 | BioPortfolio

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resistant, Gram-negative bacteria. The company’s pipeline includes ACHN-490, an aminoglycoside currently being evaluated in a Phase 2 clinical study for the treatment of complicated urinary tract infection (cUTI) and acute pyelonephritis, and late-stage preclinical programs with demonstrated in vivo efficacy against Gram-negative pathogens of concern including P. aeruginosa and A. baumannii. Resistance to available antibacterial therapies continues to rise at an alarming rate and Achaogen is applying its anticipatory science to meet this evolving need, developing drugs today intended to combat tomorrow’s resistant pathogens. Achaogen has established specialized capabilities to pursue the discovery and development of new antibiotics, and has funded its growth with a blend of private investments and non-dilutive funding from partnerships with the NIH, the United States Department of Defense, and others. For more information, please visit the company’s website at

News Articles [19 Associated News Articles listed on BioPortfolio]

Achaogen, Crystal Bioscience pen antibody discovery deal

In a multi-year collaboration, Achaogen Inc. and Crystal Bioscience Inc. are teaming up to discover monoclonal antibodies against multiple targets of interest to Achaogen.

BRIEF-Achaogen updates on $25 mln financing

* Achaogen Inc says it raised about $25 million through sale of certain securies that included equities - sec filing

Achaogen closes $25mm PIPE

Achaogen Inc. (developing antibacterials for multi-drug resistant Gram-negative infections) grossed $25.2mm through the private placement of 8mm common shares at $3.15 (a 7% premium) to lead investor ...

BRIEF-Achaogen reports Q1 loss per share $0.66

* Achaogen Inc says contract revenue totaled $5.8 million for q1 of 2016 compared to $4.9 million for same period of 2015 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-...

BRIEF-Achaogen adds Tobin Schilke as chief financial officer

* Achaogen Inc says Schilke most recently served as CFO and company director of Roche Products Limited in United Kingdom Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-6...

Tobin Schilke Appointed Achaogen CFO

Achaogen Inc. a biopharma developing antibacterial addressing multi-drug resistant gram-negative infections, has appointed Tobin Schilke chief financial officer (CFO). For...   

Achaogen Completes Patient Enrollment in Phase 3 EPIC Clinical Trial of Plazomicin

SOUTH SAN FRANCISCO, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant...

BRIEF-Achaogen, Crystal Bioscience enter into license agreement

* Achaogen and Crystal Bioscience enter into collaboration and license agreement to identify and develop antibodies for multiple targets Source text for Eikon: Further company coverage: (Bengalur...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Achaogen, Inc.

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resista...


Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.Â...

More Information about "Achaogen, Inc." on BioPortfolio

We have published hundreds of Achaogen, Inc. news stories on BioPortfolio along with dozens of Achaogen, Inc. Clinical Trials and PubMed Articles about Achaogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achaogen, Inc. Companies in our database. You can also find out about relevant Achaogen, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record